---
schema_version: "secwatch.filing_event.v1"
accession: "0001012975-25-000992"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2025-12-31T23:59:59+00:00"
generated_at: "2026-05-16T11:53:02.813366+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oramed completes Scilex warrant repurchase; receives $28.5M total

## Summary
- Scilex repurchased second tranche of 3,370,000 warrants for $14M on Dec 30, 2025.
- Oramed also received a $750,000 option fee for the second tranche.
- Total aggregate proceeds from both tranches and fees equal $28.5M.
- First tranche of 3,130,000 warrants was repurchased for $13M in September 2025.
- Subject warrants had an exercise price of $0.01 per share of Scilex common stock.

## SEC filing metadata
- accession: 0001012975-25-000992
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2025-12-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000101297525000992/0001012975-25-000992-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000101297525000992/ormp-20251230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001012975-25-000992
- JSON: https://secwatch.observer/filing/0001012975-25-000992.json
- Plain text: https://secwatch.observer/filing/0001012975-25-000992.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.